Last reviewed · How we verify

NCT03874169

Detection of Gastrointestinal Bleeding in Intensive Care Patients Via Biosensor Watch

Terminated Last updated 3 May 2023
What this trial tests

trial testing E4 wristband in Gastro Intestinal Bleeding in 20 participants. Terminated before completion.

Timeline
29 March 2019
Primary endpoint
20 July 2021
20 July 2021

Quick facts

Lead sponsorColumbia University
StatusTerminated
Study typeOBSERVATIONAL
Enrollment20
Start date29 March 2019
Primary completion20 July 2021
Estimated completion20 July 2021
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Columbia University

Who can join

25 and older, any sex, with Gastro Intestinal Bleeding. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study to improve methods of monitoring and diagnosing gastrointestinal bleeding via the E4 wristband, a biosensor watch.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Columbia University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03874169.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing